GlassScriptPhysician profile
Paul A Akerman
NPI 1942302773
$122,848.38
in general payments reported to CMS, 2019-2025
30 companies · $4,347 in 2025
The $4,347 reported for 2025 was more than what 90% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,389 · 2020: $3,706 · 2021: $2,265 · 2022: $2,812 · 2023: $1,122 · 2024: $103K · 2025: $4,347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $92K · Consulting Fee: $12K · Food and Beverage: $4,401 · Travel and Lodging: $82.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $92,046.10 |
| Consulting Fee | $12,147.50 |
| Food and Beverage | $4,400.76 |
| Travel and Lodging | $82.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $92,046.10 | 2024 | |
| Spirus Medical LLC | $8,250.00 | 2024-2025 | |
| Olympus Corporation of The Americas | $7,994.28 | 2019-2024 | Evis Exera III Duodenovideoscope, Single Use Electrosurgical Knife Kd-655, Single Use Repositionable Clip |
| Gyrus Acmi, INC. | $4,620.00 | 2019-2022 | |
| Abbvie INC. | $3,319.88 | 2019-2025 | Linzess, Rinvoq, Skyrizi |
| Olympus Corporation | $1,762.20 | 2019-2025 | Single Use Electrosurgical Snare Sd-400 |
| Keymed (Medical and Industrial Equipment) LTD | $840.00 | 2020-2021 | |
| Celgene Corporation | $590.44 | 2022-2024 | Zeposia |
| Olympus America INC. | $406.85 | 2019-2022 | |
| Pfizer INC. | $334.62 | 2021-2025 | |
| Medtronic, INC. | $282.95 | 2024-2025 | Gi Genius, Pillcam |
| Fujifilm Healthcare Americas Corporation | $261.42 | 2019-2024 | |
| Janssen Biotech, INC. | $256.30 | 2019-2025 | Tremfya |
| Micro-Tech Endoscopy USA, INC. | $214.23 | 2024-2025 | Lesionhunter |
| E.R. Squibb & Sons, L.L.C. | $203.54 | 2022-2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $198.85 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $188.00 | 2019-2023 | Xifaxan |
| Gilead Sciences, INC. | $159.00 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $146.76 | 2019-2025 | Entyvio |
| Nestle Healthcare Nutrition INC. | $127.45 | 2021-2023 | |
| Ethicon US, LLC | $122.00 | 2019 | |
| Cook Medical LLC | $120.86 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $107.34 | 2022-2025 | Dupixent |
| Intercept Pharmaceuticals, INC. | $87.98 | 2022-2023 | Ocaliva |
| Ironwood Pharmaceuticals, INC | $80.95 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $69.70 | 2022-2024 | Rebyota |
| Lilly USA, LLC | $27.21 | 2024 | Omvoh |
| Ardelyx, INC. | $16.52 | 2023 | Ibsrela |
| Merck Sharp & Dohme LLC | $12.95 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$100,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Akerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.